Research Status and Trends of Traditional Chinese Medicine Treatment for Multiple Sclerosis Based on CiteSpace Visualization Analysis
10.16466/j.issn1005-5509.2025.06.015
- VernacularTitle:基于CiteSpace可视化分析中医药治疗多发性硬化的研究现状及趋势
- Author:
Yilan ZHENG
1
;
Xiaorui GUAN
;
Yufan WU
Author Information
1. 北京中医药大学东直门医院 北京 100700
- Publication Type:Journal Article
- Keywords:
multiple sclerosis;
traditional Chinese medicine;
CiteSpace;
visual analysis;
bibliometrics;
research hotspots;
collaborative network;
keywords analysis
- From:
Journal of Zhejiang Chinese Medical University
2025;49(6):758-768
- CountryChina
- Language:Chinese
-
Abstract:
[Objective]To analyze the current research status and hot topics of traditional Chinese medicine(TCM)in the treatment of multiple sclerosis(MS),and provide references for clinical decision-making,future research and the construction of integrated Chinese and western medicine treatment guidelines.[Methods]Relevant literature published from January 2004 to November 2024 was retrieved from the CNKI,VIP,Wanfang,PubMed and Web of Science(WOS)databases.Using CiteSpace 6.3.R1 software,a visual analysis was performed on publication time,authors,institutions and keywords through co-occurrence,clustering and burst analysis to derive the current research status and hot topics.[Results]A total of 168 articles were included.The number of publications in the field of TCM treatment for MS remained relatively stable in recent years,but the proportion of high-quality clinical studies increased.A stable core group of authors was not yet formed,and research institutions were concentrated in major university-affiliated hospitals and traditional Chinese medicine institutions.High-frequency and high-centrality keywords included syndrome differentiation and treatment,renowned physician experience,integrative Chinese and western medicine,etiology and pathogenesis,and TCM syndromes.[Conclusion]TCM treatment for MS is still in the development stage,with a focus on research related to etiology,pathogenesis and syndrome differentiation.Future efforts should emphasize team and institutional collaborations,development of multi-center networks,improvement of research quality,and exploration of interdisciplinary and multi-modal treatment approaches.High-quality evidence-based research should be promoted to inform clinical decision-making,improve treatment protocols,and contribute to the development of integrated Chinese and western medicine treatment guidelines.
